Melanin Synthesis Inhibitor

Name
Melanin Synthesis Inhibitor
Accession Number
DBCAT003530
Description

Not Available

Drugs
DrugDrug Description
HydroquinoneA topical brightening agent used for the treatment of skin disorders associated with hyperpigmentation including melasma, post-inflammatory hyperpigmentation, sunspots, and freckles.
Methyl undecenoyl leucinateMethyl undecenoyl leucinate is an active ingredient in whitening creams. It is an α-MSH antagonist that inhibits melanin synthesis and tyrosinase activity and reduces expression of various melanogenic genes.
Drugs & Drug Targets
DrugTargetType
HydroquinoneTyrosinasetarget
HydroquinoneSerum albumincarrier
HydroquinoneLysosomal alpha-glucosidaseenzyme
HydroquinoneCysteinyl leukotriene receptor 1target